CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Tuesday, March 3, 2020 at 4:30 p.m. ET to review its fourth quarter and full year 2019 ...
-- Enrollment Completion for MARIO-275, Infinity’s Global, Randomized Phase 2 Study in Patients with Urothelial Cancer, Expected in 2020 with Data Expected in 2021 -- -- Initial Data from Phase 2 ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Wednesday, October 30, 2019 at 4:30 p.m. ET to review its third quarter 2019 financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results